Hisamitsu Pharmaceutical Co Inc
F:HPX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hisamitsu Pharmaceutical Co Inc
F:HPX
|
JP |
|
Alsea SAB de CV
OTC:ALSSF
|
MX |
|
A
|
Aptamer Group PLC
LSE:APTA
|
UK |
|
O
|
Omer SpA
MIL:OMER
|
IT |
|
Optare Solutions SA
MAD:OPTS
|
ES |
|
Atea ASA
OSE:ATEA
|
NO |
|
AXP Energy Ltd
ASX:AXP
|
AU |
|
C
|
Cardinal Health Inc
XMUN:CLH
|
US |
|
Mont Royal Resources Ltd
OTC:MTRRF
|
AU |
|
Briscoe Group Ltd
NZX:BGP
|
NZ |
|
E
|
Erlebnis Akademie AG
DUS:EAD
|
DE |
|
Duni AB
STO:DUNI
|
SE |
|
Catena AB
STO:CATE
|
SE |
|
J
|
JD.com Inc
XMUN:013C
|
CN |
|
Airports of Thailand PCL
SET:AOT
|
TH |
|
C
|
Clariane SE
SWB:KO2
|
FR |
|
JD.com Inc
HKEX:89618
|
CN |
|
K
|
Keyrus SA
PAR:ALKEY
|
FR |
Bankruptcy Probability
Hisamitsu Pharmaceutical Co Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hisamitsu Pharmaceutical Co Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
H
|
Hisamitsu Pharmaceutical Co Inc
F:HPX
|
2.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
344.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
213B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
181.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
268.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
130.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hisamitsu Pharmaceutical Co Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hisamitsu Pharmaceutical Co Inc has total debt of 1.1B JPY. This includes both short-term (0 JPY) and long-term (1.1B JPY) debt.
You can find a full breakdown on its Balance Sheet.